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INTRODUCTION 
 
Italy was the first European country to suffer from the 
COVID-19 pandemic. A main characteristic of this 
pandemic, besides high infectivity of its causative 
agent, is a cytokine storm characterized by an IL-6 
centered response [1, 2] and the uneven distribution of 
severity and mortality among different age classes. 
Indeed, old people, and particularly those with one or 
more comorbidity, appear to be the most vulnerable  
[3, 4]. The reasons of such a high vulnerability to 
COVID-19 is poorly understood but it has been 
suggested that a major role is played by inflammaging 
[5–7], i.e. the low-grade chronic inflammation that is a 
major driver of aging [8] and whose basic underlying 
mechanisms are shared with those responsible for frailty 
and age-related diseases (ARDs), including 
cardiovascular disease, type 2 diabetes, chronic 
obstructive pulmonary disease, chronic kidney disease 
and dementia, among others [9–11]. However, a major 
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Italy was the first European nation to be affected by COVID-19. The biggest cluster of cases occurred in 
Lombardy, the most populous Italian region, and elderly men were the population hit in the hardest way.  
Besides its high infectivity, COVID-19 causes a severe cytokine storm and old people, especially those with 
comorbidities, appear to be the most vulnerable, presumably in connection to inflammaging. In centenarians 
inflammaging is much lower than predicted by their chronological age and females, presenting survival 
advantage in almost all centenarian populations, outnumber males, a phenomenon particularly evident in 
Northern Italy. Within this scenario, we wondered if: a) the COVID-19 mortality in centenarians was lower than 
that in people aged between 50 and 80 and b) the mortality from COVID-19 in nonagenarians and centenarians 
highlighted gender differences.  
We checked COVID-19-related vulnerability/mortality at the peak of infection (March 2020), using data on total 
deaths (i.e. not only confirmed COVID-19 cases). Our conclusion is that excess mortality increases steadily up to 
very old ages and at the same time men older than 90 years become relatively more resilient than age-matched 
females. 
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characteristic of old people is their heterogeneity 
regarding not only their health status (presence/absence 
of comorbidities, frailty, cognitive status) but also, in 
particular, their different capability to mount an immune 
response to pathogens and vaccines [12, 13]. At present 
it is possible to quantify such heterogeneity using a 
variety of proteomic [15] and epigenetic biomarkers 
[16] capable of distinguishing between chronological 
and biological age, and to predict the risk of developing 
major ARDs. In particular, we showed that 
centenarians, i.e. subjects who avoided or largely 
postponed all major ARDs, and their offspring, are 
characterized by being healthier than age-matched 
controls born from non-long-living parents, i.e. a slower 
aging and are biologically younger than their 
chronological age of about 9 and 5 years, respectively. 
Particularly important within the scenario of COVID-19 
pandemic is that centenarians have a peculiar 
state/degree of inflammaging, which is much lower than 
that predicted by their chronological age and is biased 
toward anti-inflammaging, i.e. the production of anti-
inflammatory molecules and cells that the body 
produces lifelong as an adaptive, compensatory 
mechanisms to continuously down-regulate the 
inflammatory process and avoid its chronic detrimental 
effects [18–20]. Accordingly, the oldest old, including 
centenarians, are high-selected, exceptionally robust 
subjects that can be taken as a model of 
successful/healthy aging [21].  
 
A major characteristic of human longevity is the 
ubiquitous female survival advantage. In particular, 
centenarian females outnumber males [22], and this 
demographic phenomenon is particularly evident in 
Northern Italy, including Lombardy [23]. However, 
although women live longer, they suffer greater 
morbidity, particularly late in life. In Trieste, a city 
situated in the North-East of Italy with 204,000 
inhabitants, the prevalence of centenarians is high: in 
mid-June 2020 there were 148 centenarians, number 
obtained from the list of the public health service 
considering only subjects who have reached 100 years 
of age. In 2014 we started the Centenari a Trieste (CaT) 
Study, to examine the centenarians living in Trieste. 
From 2014 to January 2020 we enrolled, visited and 
collected data of 130 centenarians, using the annual lists 
provided by the public health service mentioned above. 
90% of our centenarian population are women, but the 
few males are all in excellent health [24]. The complex 
reasons of such a female longevity advantage/paradox is 
still unclear [25, 26] but it is likely the result of a 
mixture of biological (e.g. genetics) and non-biological 
(e.g. cultural, anthropological) factors [27, 28].  
 
Within this scenario, and considering that the 
population age 100 years and older is part of the fastest 
growing segment of the population worldwide, we 
thought worthwhile to check COVID-19-related 
vulnerability/mortality in old people across the above-
mentioned large and heterogeneous age spectrum, 
focusing on nonagenarians and centenarians and gender, 
in Lombardy, the largest (10 million inhabitants) and 
most populous Italian Region, heavily affected by 
COVID-19 pandemic. To this regard, our study refers to 
the peak of infection (March 2020) when the number of 
(reported) infected people was 76,586 and the number 
of deaths was 11,399 (data from the Italian Civil 




The following questions/ hypotheses were addressed/ 
tested: i) is the COVID-19-related mortality of 
exceptionally long-living subjects, lower than that of 
people in the age-range between 50 and 80 years of 
age? ii) do the COVID-19-related mortality data show 







During March 2020 a large increase in mortality was 
seen in Lombardy relative to previous years, both in 
absolute and in relative terms: against a background of 
8492 deaths (mean of March deaths between 2015 and 
2019), in 2020 there were 24,330 deaths, constituting an 
increase of 15,838 in absolute numbers and of 286% in 
percentage. Men contributed more to this increase with 
9021 (57.0%) extra deaths. Increase in mortality is 
apparent in older age groups. In fact, while excess 
mortality under 40 years of age totalized less than 50 
persons, its maximum was reached in the 80-84 and 85-
89 age categories, with about 3300 more deaths each 
(Supplementary Figure 1).  
 
When percent excess death by age class was plotted, a 
continuous increase in mortality by age was apparent 
(Figure 1, panel A). This phenomenon was clearly 
visible in both men (Figure 1, panel B) and in women 
(Figure 1, panel C), where March 2020 mortality is 
compared with mean March mortality of the previous 
years. However, the two patterns had also some 
differences: in women the increase resulted in 
approximately a doubling in mortality risk in each age 
class, whereas in men the greatest relative increase was 
in "younger" ages, were 2020 mortality was more than 
three times that of previous years, while in later ages the 
increase is about 80%. These different changes result in 
two different patterns of increase by age, i.e. women 
increase in excess mortality was lower in "younger" 
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ages, but reached that of men in later ages (Figure 1, 
panel D): while excess mortality under 90 was much 
higher in men, it was similar in the nonagenarians and 
in centenarians women even had a higher mortality.  
 
We tested if the increase in mortality by age was 
different between men and women entering an 
interaction (age*sex) term in a logistic model: the effect 
was statistically significant (p<0.0001). We further 
refined the model entering age also as a quadratic term, 
together with its interaction with sex (age squared*sex): 
the interaction term resulted statistically significant 
(p<0.0001). This latter model was statistically better 
than the simpler one (p<0.0001). Both models indicated 
that the probability of dying was much higher in 
"young" men, but that at older ages the difference was 
less pronounced (simpler model) or even reversed 
(model with quadratic age). 
Mortality in Trieste 
 
Owing to the above-mentioned large heterogeneity of 
the health status of elderly subjects including 
nonagenarians and centenarians [12–14], and 
considering that morbidity, mortality and longevity 
outcomes are largely context-dependent [27, 28], it is 
interesting to look at what can be observed with a 
higher “granularity”.   
 
In March 2020 in Trieste there were 138 centenarians, 
90% of them were women (Figure 2). 71 centenarians 
were tested with swab for COVID-19: three of them 
resulted positive but subsequently became negative at 
test and were therefore considered cured of COVID-
19 infection. The remaining 68 centenarians tested 
negative for COVID-19: four of them died of old  age 




Figure 1. Mortality in March 2020 in Lombardy compared with mean mortality in March in 2015-2019. (A) Percent March 2020 
excess mortality, by age class. (B) Men percent mortality by age class and year. (C) Women percent mortality by age class and year. 
(D) Percent March 2020 excess mortality by age class and sex. 
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As part of the CaT Study, from October 2019 to January 
2020, immediately before medical emergency for 
COVID-19, we enrolled 42 centenarians using the list 
of the public health service, 39 women and 3 men 
(Figure 2). Six centenarians died before April 2020: five 
women for senectus and without symptoms related to 
COVID-19 infection. A man was admitted in a ward 
COVID-19 infected and was the only one dying with 
COVID-19 pathology. A woman of the 42 centenarians 
enrolled in the Study tested for COVID-19 was negative 
despite living in a nursing home with a COVID-19 
outbreak, where most of the other elderly guests became 
positive. She was one of the centenarians belonging to 




The answer to the first question (is the COVID-19-related 
mortality of exceptionally long-living subjects lower than 
that of people in the age-range between 50 and 80 years 
of age?) is negative.  In a region such as Lombardy which 
experienced a high SARS-CoV-2 infection rate, we 
found a continuous increase in mortality by age when 
percent excess death by age class was plotted. On the 
whole, nonagenarians and centenarians, despite their 
capability to survive until an extreme age and to 
avoid/postpone most of the ARDs, could be highly 
vulnerable during personal and societal stressful events 
like as seen during the SARS-CoV-2 pandemic.  These 
data are in accord with the hypothesis that a major reason 
of such increasing vulnerability of the elderly, including 
nonagenarians and centenarians, to COVID-19 infection 
and related stressful conditions is inflammaging, the age-
related increase of the inflammatory status which is 
particularly deleterious in those old subjects affected by 
one or more comorbidities. Inflammaging is a complex 
phenomenon at present only partially understood which 
can be highly different and personalized in different 
individuals [29]. Accordingly, the conceptual framework 
of inflammaging could help in understanding both the 
higher vulnerability of the elderly to COVID-19 but also 
the different responsiveness to COVID-19 infection and 
related contextual stressors in different subsets of elderly 
people.  
 
The take home message is that nonagenarians and 
centenarians need particular attention, protection and 
special care in situations challenging the capability of 
hospitals, nursing homes and Health Service to cope 
with exceptional events like the COVID-19 pandemic.  
 
However, when mortality is disentangled according to 
gender a peculiar gender-specific crossing emerged. The 
excess of mortality presumably due, directly or 
indirectly, to COVID-19 explosively grew in males 




Figure 2. COVID-19 testing and deaths in Trieste (left) and in the CaT (Centenari a Trieste) Study (right). 
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rise tended to slow down. Females had a similar age 
trend, but their risk was lower in lower ages than in 
males and the decrease in higher age groups was less 
marked. Thus, very old people such as nonagenarian 
and centenarian males appears to be more resilient than 
age-matched females. 
 
Accordingly, the answer to the second question (do the 
COVID-19-related mortality data show any gender 
difference in nonagenarians and centenarians?) is 
positive.    
 
The reasons of such gender-specific trajectories of 
resilience are unclear. We reported that in men a genetic 
predisposition to produce high levels of IL-6 is 
detrimental for longevity [30]. In subjects with ages 
ranging from 22 to 93 years the age-related decline in 
adaptive immunity (particularly T cells) and especially 
the activation of innate immunity despite being present 
in both women and men were significantly greater in 
magnitude in men, suggesting that they experience a 
stronger inflammaging than women even when the 
subjects were otherwise healthy and clinically 
comparable in terms of age, BMI, and ethnicity [31]. 
Men have also a stronger inflammatory state in 
circulating monocytes compared to women [31]. Thus, 
men-specific immune characteristics interacting 
with/related to inflammaging, such as a blunted 
acquired immune system and type I interferon response, 
coupled with the downregulation of ACE2 (SARS-
CoV-2 receptor) (particularly in patients with age-
related comorbid diseases such as type II diabetes) and 
an accelerated biological aging (measured by epigenetic 
markers and telomere shortening), could help in 
explaining the higher vulnerability of men to COVID-
19 infection [32].  
 
To understand why men older than about 90 years 
become relatively more resilient than age-matched 
females it is important to consider the above-mentioned 
female-male health-survival paradox [25, 26, 33]. 
Indeed, despite women live longer than men and appear 
to be stronger even during severe famines and 
epidemics [34] when they became nonagenarians and 
centenarians show a much worse health status than that 
of nonagenarian and centenarian men who have a much 
better physical and cognitive health. The more years of 
life expectancy of women are mostly years of disease 
and disability [27, 28]. In any case, nonagenarians and 
centenarians are a mix of those aging well and those 
aging poorly, and in this heterogeneous scenario men 
capable of reaching age 90 and especially 100 are likely 
the more robust. Centenarian men are fewer but more 
selected and healthier and likely more resilient than 
centenarian women in highly stressful conditions like 
COVID-19 pandemic.  
Finally, it is important to note that the two general 
conclusions of our study, i.e. the high COVID-19-
related mortality of nonagenarians and centenarians and 
the relative resilience of male centenarians, resulting 
from epidemiological investigations can be at variance 
with anecdotal observations that centenarians and 
sometime supercentenarians (people over 110 years old) 
survived and recovered after COVID-19 infection. As 
an example, our data on a low number of very well 
characterized subjects of the CaT Study, suggest that 
both centenarian women and men looked strong during 
the peak of COVID-19 pandemic which profoundly 
challenged the entire health system and care of the 
elderly. What can be observed and reported at a higher 
magnification and higher granularity in single cities, 
institutions and settings is the consequence of the basic 
heterogeneity of the aging phenotype which is 
particularly evident at the extreme ages and suggests 
that outcomes may differ by robustness or other 
characteristics of the individual and are always highly 
diverse and context-dependent. To this regard, it can be 
predicted that the use of proteomic [15], epigenetic [16, 
17] and glycomic biomarkers [35], among others, 
capable of distinguishing between chronological and 
biological age, will help in disentangling the 
heterogeneity of the aging phenotypes and in 
identifying the elderly characterized by an accelerated 
aging and lower robustness and thus at higher risk of 
morbidity and mortality in normal as well in exceptional 
circumstances such the COVID-19 pandemic.    
 
Strength and limitations 
 
We had access to open data provided by Istat, which 
despite being a non-representative subset of Italian 
municipalities covers the Lombardy population almost 
completely (about 97%). The data on the entire Italian 
population would have diluted the results here 
presented, owing to the much lower mortality in the 
other Italian regions. 
 
We analyzed total mortality and not COVID-19-related 
deaths. This is both a limitation and a strength. Due to 
the great strain imposed on the Italian National Health 
Service, particularly in the hardest hit provinces, we 
cannot exclude an increase in general mortality due to a 
missing response to needs that would have been 
otherwise met. Even if this may not be excluded, we 
find difficult to think of logistical reasons that would 
differentially impact men and women and spare oldest 
men. Analyzing only confirmed COVID-19 deaths is 
more specific but, due to the impressive surge in 
mortality, only a part of those who died due to the 
infection were reported as being infected, and only a 
part of them was subject to a verification. Also, in 
absence of clear typical manifestations, a part of 
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COVID-19 mortality could be incorrectly attributed to 
other causes, even after a closer reanalysis, since swabs 
were only partially available, and their sensitivity is far 
from perfect. 
 
In conclusion, we reported data that clearly show that 
old people, including nonagenarians and centenarians, 
suffered a high COVID-19-related mortality in the 
Lombardy region and suggested that the conceptual 
framework of inflammaging could help in 
understanding such age-related vulnerability. The 
remarkable difference between women and men in life 
expectancy, disability, mortality and longevity which 
emerged also in circumstances such as the COVID-19 
pandemic is complex but still poorly understood and 
deserves attention and a closer scrutiny. Preventive 
strategies focused on the elderly preparing us better for 
the next pandemic are urgently needed [6]. 
 
MATERIALS AND METHODS 
 
We used publicly available online data from the Istat 
(Italian Institute of Statistics) site: https://www.istat.it/ 
it/archivio/240401 (accessed on June 15, 2020). 
Mortality raw data in a large dataset of Italian 
municipalities were collected by ANPR (National 
Registry of Resident Population) operated by the 
Ministry of the Interior. These data were successively 
merged with the dataset of the Registry Tax operated by 
the Ministry of Economy and Finance, validated and 
made available on-line by Istat. 
 
Mortality data were made available for each day starting 
from January 1 to Apr 30, 2020 by municipality, 5-year 
age classes, and sex. Reference mortality data are 
available for the years 2015 to 2019, with same 
granularity. 
 
Since we wanted to study the effect of the virus on 
mortality by age we concentrated on the Lombardy 
region, which presently (June 15, 2020) accounts for 
almost half of the confirmed COVID-19 deaths in Italy, 
and on the peak of infection (March 2020). Notably the 
dataset covers 97.1% of the Lombardy population. 
 
Population in Italy (and as a consequence also in 
Lombardy) is gradually ageing, rendering impossible a 
direct comparison of 2020 deaths to 2015-2019 deaths.  In 
order to correct for this imbalance we calculated the 2020 
death percentage comparing the number of deaths within 
age classes with the respective age class populations, i.e. 
[(March 2020 number of deaths)/(March 2020 Lombardy 
population)]*100, for each age class, by sex. Reference 
2015-2019 death percentage was calculated similarly as 
[(mean March 2015-2019 number of deaths)/(mean 
March 2015-2019 Lombardy population)] *100, for each 
age class, by sex. Percent excess mortality was calculated 
as a difference between 2020 mortality percentage and 
previous years mean mortality percentage. Lombardy 
population data was retrieved from the demo.istat.it site. 
Population data for 2020 is not available yet, so we used 
the data from the Istat population projections for 2020 
available from same site. 
 
We used logistic regression models in which age and sex 
were used as predictors for March 2020 probability of 
excess mortality, i.e. we disregarded "usual" (mean 2015-
2019) number of March deaths. Age was modelled as a 
continuous factor, and age classes were given an 
intermediate value: for example 80-84 class was given an 
82.5 value. Last class (100+) was given a 102.5 value. 
Models tried were hierarchically related: first only age 
and sex, then an interaction age*sex was entered into the 
model to test if the rate of increase was different between 
sexes. A quadratic effect, and its interaction was tried in a 
subsequent model. 
 
The protocol of the CaT study to obtain, after informed 
consent, demographic, anamnestic, clinical and lifestyle 
data from the subjects enrolled in the study was already 
published [36].  
 
JMP Pro v 15.0 (SAS Institute Inc.) was used to manage 




ACE: Angiotensin-converting-enzyme; ARD: age-
related diseases; BMI: body mass index; CaT: Centenari 
a Trieste; COVID-19: coronavirus disease 2019; SARS-
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Supplementary Figure 1. Total number of deaths in March in Lombardy, by age class and year. 
 
